Touchstone International Medical Science Co Ltd (688013) — Cash Flow-to-Debt Ratio
Touchstone International Medical Science Co Ltd (688013) has a Cash Flow-to-Debt Ratio of 0.35x as of September 2025, meaning its operating cash flow of CN¥27.05 Million could theoretically repay 0% of its total liabilities (CN¥76.41 Million) in one year. See 688013 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Touchstone International Medical Science Co Ltd Cash Flow-to-Debt Ratio (2017–2024)
Historical debt coverage capacity for Touchstone International Medical Science Co Ltd across 8 annual periods. Also explore 688013 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Touchstone International Medical Science Co Ltd (2017–2024)
Year-by-year debt coverage analysis for Touchstone International Medical Science Co Ltd. For market capitalisation and broader financial context, see 688013 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.96x | CN¥53.41 Million | CN¥55.81 Million | ▼ -36.5% |
| 2023 | 1.51x | CN¥82.95 Million | CN¥55.08 Million | ▲ +4.7% |
| 2022 | 1.44x | CN¥50.40 Million | CN¥35.04 Million | ▼ -22.9% |
| 2021 | 1.86x | CN¥60.98 Million | CN¥32.71 Million | ▼ -14.3% |
| 2020 | 2.17x | CN¥42.08 Million | CN¥19.35 Million | ▲ +10.7% |
| 2019 | 1.96x | CN¥34.82 Million | CN¥17.72 Million | ▲ +94.3% |
| 2018 | 1.01x | CN¥34.44 Million | CN¥34.05 Million | ▲ +140.2% |
| 2017 | 0.42x | CN¥7.88 Million | CN¥18.72 Million | — |